Close Menu
Humanoid Analytics
  • Companies
  • Company Tracker
  • Deployment Tracker
  • Funding Tracker
  • Deployments
  • Technology
  • Funding
  • Markets
  • Our Services
Highlights

Most Humanoid Companies Do Not Build Humanoids

November 10, 2026

China’s Block on SoftBank’s ABB Deal Tests Its Physical AI Strategy

November 9, 2026

Agility’s Nasdaq Debut Puts Humanoid Economics to the Test

November 5, 2026
X (Twitter) Mastodon LinkedIn
Humanoid Analytics
  • Companies
  • Trackers
    • Company Tracker
    • Deployment Tracker
    • Funding Tracker
  • Deployments
  • Technology
  • Funding
  • Markets
  • Services
Humanoid Analytics
Home»Funding»China’s Block on SoftBank’s ABB Deal Tests Its Physical AI Strategy
Funding

China’s Block on SoftBank’s ABB Deal Tests Its Physical AI Strategy

A possible China carve-out could preserve the acquisition while changing the industrial platform SoftBank hoped to buy.
By Rinat MirzaitovNovember 9, 20264 Mins Read
AI-generated illustration.
Share
LinkedIn Twitter Copy Link Email

SoftBank’s $5.4 billion plan to buy ABB Robotics has reached a question that matters across physical AI: how much of a global robotics business can a buyer actually control?

Reuters reported on November 5 that China had blocked the acquisition. SoftBank’s November 6 disclosure clarified the scope: Chinese authorities prohibited the purchase of ABB’s robotics business in China, with notification received on November 4. SoftBank said both companies were still working on the transaction. The immediate investor question is what assets and rights an acceptable deal would contain. A revised agreement and regulatory clearance remain missing.

By November 7, Reuters, citing Bloomberg reporting, described discussions about separating the Chinese operations into an entity with different ownership. ABB declined to comment, and SoftBank did not respond to Reuters’ request. That is a reported route forward, not an agreed solution.

What SoftBank wanted to buy

The agreement signed on October 8, 2025 set a purchase price of $5.375 billion, subject to adjustments, with closing originally expected in mid-to-late 2026. SoftBank presented the acquisition as part of its physical AI strategy, combining ABB’s industrial robotics expertise and customer relationships with its AI investments.

There was an established business behind that ambition. SoftBank published ABB-supplied, pro forma unaudited figures showing robotics revenue of $2.279 billion and operational EBITA of $277 million for 2024. Those historical figures describe the business before any potential China separation.

Humanoid Analytics’ interpretation is that ABB offered SoftBank a route into industrial customers and working production environments. Those relationships could help bring more capable AI into real workflows. The relevance to humanoids lies in that commercial infrastructure. This transaction itself provides no new evidence of humanoid reliability, autonomy or deployment economics.

China accounts for about 30% of ABB’s robotics business, according to Reuters. A carve-out could therefore change the acquisition’s commercial value substantially. Its effect would depend on the revenue retained, manufacturing arrangements, intellectual-property rights and ability of the separated businesses to cooperate.

The original price cannot simply be treated as the price of whatever remains.

The next test is the deal’s shape

Reuters reported concerns about sensitive data reaching the United States and SoftBank’s ties to Western companies, including OpenAI, citing a person familiar with the transaction. SoftBank’s public update did not explain the regulator’s reasoning. The data concern remains an attributed explanation, not a published regulatory finding.

For investors and robotics companies considering cross-border acquisitions, the case illustrates why ownership, data access and regulatory permission belong in the same commercial assessment. A technically useful combination may still require a structure that limits how its businesses can share technology or operate together.

Separation could preserve much of SoftBank’s strategic rationale if it retains valuable customers, technology and manufacturing capabilities. It could also introduce costs and restrictions that weaken the expected benefits. The disclosed information does not yet establish either outcome.

The evidence to watch is concrete: a signed revised agreement, the assets and rights included, updated consideration, required approvals and a credible closing timetable.

SoftBank may still secure an important industrial platform for physical AI. Its value will depend on the business it can actually acquire, and the freedoms that come with it.

Sources:

  1. Reuters, “China blocks SoftBank’s $5.4 billion takeover of ABB’s robotics division”
    Source type: Tier 2, strong independent evidence. Named ABB confirmation supports the prohibition; explanations of officials’ concerns rely on anonymous sources.
    https://www.reuters.com/business/media-telecom/china-blocks-softbanks-54-billion-takeover-abbs-robotics-division-ft-reports-2026-11-05/
  2. SoftBank Group Corp., “Update on Acquisition of ABB Ltd’s Robotics Business”
    Source type: Tier 3, detailed first-party disclosure. Company-controlled source, November 6, 2026.
    https://group.softbank/en/news/press/20261106
  3. Reuters, “SoftBank, ABB explore China carve-out to salvage robotics deal, Bloomberg News reports”
    Source type: Tier 2, strong independent evidence. The carve-out account relays Bloomberg’s anonymous sourcing and is not independent corroboration of that account.
    https://www.reuters.com/business/media-telecom/softbank-abb-explore-china-carve-out-salvage-robotics-deal-bloomberg-news-2026-11-07/
  4. SoftBank Group Corp., “Acquisition of ABB Ltd’s Robotics Business”
    Source type: Tier 3, detailed first-party disclosure. Company-controlled source, October 8, 2025.
    https://group.softbank/en/news/press/20251008
Confirmed Claim Market Signals The Brief
Share. LinkedIn Twitter Copy Link Email

Related Analysis

Agility’s Nasdaq Debut Puts Humanoid Economics to the Test

November 5, 2026

Faraday Future’s US$200 million robotics deal remains non-binding

October 1, 2026

Leaderdrive Approves Hong Kong H-Share Plan, but HKEX Filing Is Not Yet Verified

September 2, 2026

Unitree’s $50 Billion Debut Makes Public Disclosure the New Test

August 21, 2026
Selected Analysis

Most Humanoid Companies Do Not Build Humanoids

November 10, 2026

Agility’s Nasdaq Debut Puts Humanoid Economics to the Test

November 5, 2026

China Has More Humanoid Companies Than the Rest of the World Combined

November 3, 2026

Humanoid Analytics tracks the commercial progress of humanoid robotics through evidence-based analysis, company profiles, deployment trackers, and market intelligence.

Connect with us:

X (Twitter) Mastodon LinkedIn RSS
Highlights

Most Humanoid Companies Do Not Build Humanoids

November 10, 2026

China’s Block on SoftBank’s ABB Deal Tests Its Physical AI Strategy

November 9, 2026

Agility’s Nasdaq Debut Puts Humanoid Economics to the Test

November 5, 2026
Stay Informed

Subscribe to Updates

Get evidence-based updates on humanoid robotics companies, deployments, funding, partnerships, and market signals.

  • Home
  • About Us
  • Our Services
  • Evidence Standards
  • Contact Us
  • Privacy Policy
  • Terms of Use
© 2026 Humanoid Analytics. All rights reserved.

Type above and press Enter to search. Press Esc to cancel.